Skip to content
zameds

Drospirenone

Schedule 3 to 4, conditions apply
Loading the molecular structure
C24H30O3366.50 g/mol

(1R,2R,4R,10R,11S,14S,15S,16S,18S,19S)-10,14-Dimethylspiro[hexacyclo[9.8.0.02,4.05,10.014,19.016,18]nonadec-5-ene-15,5'-oxolane]-2',7-dione

Drag to rotate; arrow keys step through the atoms. Structure from PubChem CID 68873.

Listing

Schedules
Schedule 3 to 4, conditions apply
Source
Consolidated Schedules 06 July 2026

Registered medicines

2 registered products listed

Counted through the register's ingredient index, which does not reach every record.

Registered products
NameBrandsDosagesApplicantsRegistrationsSchedule
DrospirenoneYasmin, Angeliq, Yaz, +32 more0,02 mg, 3,0 mg, 0,03 mg, 3,0 mg, 0,03 mg 3/0,, 1.0 mg/2.0 mg, +7 more12 applicants36 registrationsS4

5 more registered products name Drospirenone in their active ingredient

Registered products
NameBrandsDosagesApplicantsRegistrationsSchedule
YasminYasmin3mgBayer (Pty) Ltd û Isando340494S3
YazYaz3mgBayer (Pty) Ltd û Isando410842S4
RubyRuby3 mg/0,03 mgPharma Dynamics (Pty) Ltd430648S3
JarinaJarina3 mg/0,03 mgBayer (Pty) Ltd û Isando430782S3
YnezYnezNot statedAdcock ingram limited440397
Cloelle CancelledCloelleNot statedAdcock ingram limited440398
EloineEloine3 mgBayer (Pty) Ltd û Isando440957S4
Maya CancelledMayaNot statedTeva Pharmaceuticals (Pty) Ltd470024
Yade CancelledYadeNot statedTeva Pharmaceuticals (Pty) Ltd470025
DrasiraDrasiraNot statedCipla Medpro (Pty) Ltd470141
Drospirenone/ethinylestradiol Adco CancelledDrospirenone/ethinylestradiol adco3/0,02 MGAdcock ingram limited470702
EthodrosEthodrosNot statedAdcock ingram limited470704
Show the other 21 registered products
Registered products
NameBrandsDosagesApplicantsRegistrationsSchedule
Nezdropaz CancelledNezdropazNot statedAdcock ingram limited470705
Uvisma Forte CancelledUvisma forteNot statedRanbaxy (SA) (Pty) Ltd481025
Uvisma CancelledUvismaNot statedRanbaxy (SA) (Pty) Ltd481026
DebigenDebigenNot statedViatris South Africa (Pty) Ltd481252
GinorelleGinorelleNot statedCipla Medpro (Pty) Ltd500343
ContrezContrez0,02 mg, 3,0 mgInnovata pharmaceuticals500517
ContrezinContrezin0,03 mg, 3,0 mgInnovata pharmaceuticals500590
RubazRubaz3 mg / 0,02 mgPharma Dynamics (Pty) Ltd50342S4
EsdopilEsdopil0,03 mg 3/0,Austell Pharmaceuticals (Pty) Ltd550861
Yaz PlusYaz plus3mg/0.02 mg/0.451 mgBayer (Pty) Ltd û Isando450534S4
Yasmin PlusYasmin plus3mg/0.03 mg/0.451 mgBayer (Pty) Ltd û Isando450535S4
Ruby PlusRuby plusNot statedPharma Dynamics (Pty) Ltd580140
SperylomeSperylomeNot statedPharma Dynamics (Pty) Ltd580141.140
OcazOcazNot statedUnicorn Pharmaceuticals (Pty) Ltd470159
LeylaLeylaNot statedAustell Pharmaceuticals (Pty) Ltd470333
DrosmylDrosmylNot statedViatris South Africa (Pty) Ltd481253
SpirenylSpirenylNot statedActivo Health (Pty) Ltd501175
DrostraDrostraNot statedActivo Health (Pty) Ltd510234
DrovelisDrovelisNot statedAdcock ingram limited560933
Rubaz PlusRubaz plusNot statedPharma Dynamics (Pty) Ltd580135
RosnylevoRosnylevoNot statedPharma Dynamics (Pty) Ltd580136.135

Regulatory status

Where S3 to S4 sits on the scale

Depends on which listing applies

At the least restrictive, Schedule 3: needs a doctor's prescription, dispensed by a pharmacist. At the most restrictive, Schedule 4: prescription-only medicine. The listings below say which applies to which form, strength or pack size.

Schedule S3 to S4, as the Consolidated Schedules list it.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Drospirenone

  • S4: Drospirenone

    • when intended for hormone replacement therapy;
    • except when intended for oral contraception. (S3)

    Consolidated Schedules 06 July 2026, lines 6127 to 6131

  • S3: Drospirenone

    • when intended for oral contraception;
    • except when intended for hormone replacement therapy. (S4)

    Consolidated Schedules 06 July 2026, lines 3490 to 3494

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

Background

Loading...
Loading Wikipedia summary

Research articles

Loading...
Loading PubMed articles